Abstract:Abstract Study question To investigate the efficacies of three cycle regimens in women receiving frozen embryo transfer with a history of cesarean section(CS). Summary answer In women undergoing frozen embryo transfer with a history of CS, hormone replacement therapy for endometrial preparation was associated with a higher early miscarriage rate. What is known already Rates of CS are rising worldwide. Many women with a history of a CS delivery conceived through assisted reproductive technology (ART) are in need of frozen embryo transfer (FET) for their second progeny. Various protocols for endometrium preparation have been used to provide an optimal uterine environment for the transfer of thawed embryos, but the evidence supporting the superiority of one protocol over another is insufficient. Study design, size, duration A retrospective cohort study of patients (N = 6,159) with a history of CS who fulfilled the inclusion criteria were enrolled in the study from January 2014 to December 2019 at the CITIC-Xiangya Hospital of Reproduction and Genetics. Participants/materials, setting, methods Reproductive outcomes of patients in the natural cycle （NC） (n = 4,306) versus hormone replacement therapy（HRT） (n = 1,007) versus gonadotropin-releasing hormone agonist （GnRH-a） + HRT groups (n = 846) were compared. Multiple logistic regression analyses were performed to investigate the potential confounding factors. Main results and the role of chance The unadjusted odds of the miscarriage rate of singleton pregnancies were also significantly higher in the hormone replacement therapy compared with the natural cycle (25.5% versus 20.4%, respectively). After adjusting for possible confounding factors, the early miscarriage rate and the miscarriage rate of singleton pregnancies remained significantly higher in the hormone replacement therapy than the natural cycle. The clinical pregnancy rates in the hormone replacement therapy, hormone replacement therapy and treatment with gonadotropin-releasing hormone agonist of women with a history of cesarean section was 48.8%, 48% and 47.1%, respectively, and the live birth rates were 37%, 34.1% and 35.7%, respectively. Limitations, reasons for caution This study is limited by its retrospective design. Furthermore, the detailed ultrasound information on uterine myometrial defects, complications related to CS and the number of previous CSs were unavailable in our study. Another limitation is that pregnancy-related complications and neonatal outcomes were not analyzed. Wider implications of the findings Our study could help physicians improve their understanding of the impact of different protocols on pregnancy outcomes in patients with a history of CS. Prospective randomized trials should be conducted to assess the efficacy of endometrial preparation protocols for FET in women with a history of CS. Trial registration number not applicable

Effects of serum estrogen levels before frozen-thawed blastocyst transfer on pregnancy outcomes in hormone replacement cycles

The effect of progesterone level prior to oocyte retrieval on the numbers of oocytes retrieved and embryo quality in IVF treatment cycles: an analysis of 2,978 cycles

The effect of elevated progesterone levels before oocyte retrieval in women undergoing ovarian stimulation for IVF treatment on the genomic profile of peri-implantation endometrium.

Frozen Versus Fresh Single Blastocyst Transfer in Ovulatory Women: a Multicentre, Randomised Controlled Trial.

A Comparison of Implantation, Miscarriage and Pregnancy Rates of Single and Double Day 3 Embryo Transfer Between Fresh and Frozen Thawed Transfer Cycles: a Retrospective Study.

P-407 Pregnancy outcomes of different endometrial preparation in patients with a history of cesarean section

The Relationship Between Serum Oestrogen Levels and Clinical Outcomes of Hormone Replacement Therapy-Frozen Embryo Transfer: a Retrospective Clinical Study.

THE RELATIONSHIP BETWEEN SERUM ESTROGEN (E2) LEVELS AND OUTCOMES OF HORMONE REPLACEMENT THERAPY-FROZEN EMBRYO TRANSFER (HRT-FET).

Association between duration of progesterone supplementation and clinical outcomes in artificial frozen-thawed embryo transfer cycles

Effect of HCG-day serum progesterone and oestradiol concentrations on pregnancy outcomes in GnRH agonist cycles

Effect of estrogen exposure on pregnancy outcomes in artificial frozen-thawed embryo transfer cycles

The impact of endometrial thickness change after progesterone administration on pregnancy outcome in patients transferred with single frozen-thawed blastocyst

Serum progesterone level above 0.85 ng/mL and progesterone/estradiol ratio may be useful predictors for replacing cleavage-stage with blastocyst-stage embryo transfer in fresh IVF/ICSI cycles without premature progesterone elevation

Higher serum progesterone level has no negative impact on live birth rate in frozen embryo transfer

The influence of progesterone and estradiol level on the day on clinical outcome of frozen thawed embryo transfer in nature cycle.

The effect of peak serum estradiol level during ovarian stimulation on cumulative live birth and obstetric outcomes in freeze-all cycles

Impact of progesterone level after HCG administration on the outcome of IVF in long GnRH-agonist pituitary suppression protocol

Adverse Impact of Elevated Progesterone Levels on Human Chorionic Gonadotropin Trigger Day on Blastocyst Transfer Outcomes in Gonadotropin-Releasing Hormone Agonist Cycles.

The individualized choice of embryo transfer timing for patients with elevated serum progesterone level on the HCG day in IVF/ICSI cycles: a prospective randomized clinical study

Association Between Serum Estradiol Level on the Human Chorionic Gonadotrophin Administration Day and Clinical Outcome.

Elevated luteinizing hormone levels during the artificial endometrial preparation cycle do not impact pregnancy outcomes in patients undergoing single vitrified-warmed blastocyst transfer